Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 12 of 12 for “"Tiotropium"”.
-
Cost-Effectiveness and Cost-Utility Analysis of Tiotropium Treatment for Bronchiectasis: Evidence From a Cross Over Randomised Trial
… the relative cost-effectiveness of administering tiotropium compared to a placebo in adult patients with non-cystic fibrosis (CF) bronchiectasis with airflow obstruction, from a funder perspective. Methods: Clinical efficacy data was obtained from a randomised placebo-controlled crossover study of …
-
Renewed perspective on efficacy and safety of inhaled muscarinic antagonists as asthma management therapies
… long-acting muscarinic antagonist (LAMA), tiotropium bromide (Spiriva® Respimat®), on the allergen-induced early asthmatic response in thirteen well-controlled mild allergic asthmatics. This investigation used an allergen-inhalation challenge and the indirect measures of inflammation: …
-
ANTICHOLINERGIC THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: NOVEL MECHANISMS OF ACTION
… of novel mechanisms to explore the reported tiotropium bromide-mediated improvement in exercise tolerance in COPD.</p> <p><em>Methods:</em></p> <p>We conducted a retrospective, cross-sectional analysis of 4,424 COPD patients and 4,221 healthy subjects; referred to McMaster University Medical …
-
Role of long acting bronchodilators in asthma and chronic obstructive pulmonary disease
… persistent asthma, the addition of the LAMA tiotropium to ICS/LABA adds little to airway calibre or geometry. Neither does it significantly attenuate airway hyperresponsiveness. In the group of smokers with asthma, the addition of tiotropium to ICS/LABA does significantly reduce airway …
-
Pre-clinical modeling of viral- and bacterial-induced exacerbations of chronic obstructive pulmonary disease
… the long-acting muscarinic receptor antagonist Tiotropium were tested in the established models. Furthermore, a novel treatment approach using antibodies (Abs) directed against IL-1α, IL-1β or IL-1R1 was examined in the established CS/H1N1 model. Levels of IFN-γ, IL-1β, IL-2, IL-6, KC, TNF-α, …
-
The use of MALDI-MS for imaging drug disposition in respiratory disease models.
… limit of detection. The distribution of a Tiotropium Bromide was monitored throughout the lungs following inhaled delivery. High spatial resolution imaging enabled a detailed view of the distribution of Tiotropium in the trachea and major airways.Quantitative mass spectrometry imaging is a …
-
Ανάπτυξη και βελτιστοποίηση της σύνθεσης ενος DPI με πειραματικό σχεδιασμό: Μια προσέγγιση QbD
… λειτουργία και μειωμένη ποιότητα ζωής [1-3]. Το Tiotropium είναι ένα αντιχολινεργικό φάρμακο που χορηγείται σε εισπνεόμενη μορφή προκειμένου να ανακουφίσει τα συμπτώματα της Χ.Α.Π. Οι ξηρές κόνεις προς εισπνοή (Dry Powder |Inhalers- DPIs) σε αντίθεση με τους υπόλοιπους τύπους εισπνεόμενων …
-
The Role of IL-4/IL-13 Signalling in Mucociliary Clearance in Bronchiectasis
… whereas IL-13 had no significant effect. Tiotropium (an inhibitor of mucus release) did not prevent the IL-4 induced decrease in cilia beat frequency. Finally, this project compared mucus properties in different respiratory conditions. The sputum percentage dry weight, rheology and …
-
Improved inhalation therapies of brittle powders
… fixed dose therapy using formoterol fumarate, tiotropium bromide and budesonide as therapeutic drugs. We investigated applications of this technology to powder properties and in vitro aerosol performance with respect to single and combination therapy. As a result, the brittle TFF powders …
-
Experimental and Numerical Study of Inhaler Spray Characterization (Size Distributions and Velocity)
… whereas the Spiriva Respimat inhaler using tiotropium bromide. Measurements along the pMDI centerline (at 0, 75, and 100 mm downstream of the inhaler mouthpiece) showed that the spray velocities were bimodal in time for all four pMDI brands. The first peak occurred as the spray was leaving …
-
BRONCHOPROTECTION PROVIDED BY LONG-ACTING MUSCARINIC ANTAGONISTS AND ULTRA LONG-ACTING β2 AGONISTS AGAINST METHACHOLINE-INDUCED BRONCHOCONSTRICTION IN MILD ASTHMATICS
… of bronchoprotection provided by two LAMAs, tiotropium and glycopyrronium, against methacholine-induced bronchoconstriction in mild asthmatics; the second study had a three-way crossover design for investigating the effects of glycopyrronium (LAMA) and indacaterol (uLABA), alone and in …
-
NEW THERAPEUTIC STRATEGY TO CONTRAST INFLAMMATION AND LUNG REMODELLING PROCESSES IN A MURINE MODEL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
… and bronchodilators (salmeterol and tiotropium) drugs, at different times: - mice early treated (treatment started at the first week of exposure to risk factors, for 4 weeks); - mice late treated (treatment started at the sixth week of exposure to risk factors, for 4 weeks). …